Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.93%301.85B | 8.35%311.09B | 10.77%306.66B | 9.15%1.18T | 15.61%329.34B | 6.97%282.28B | 6.92%287.11B | 6.59%276.84B | 2.28%1.08T | -2.07%284.88B |
Cost of revenue | 7.03%206.36B | 6.99%207.89B | 8.98%202.85B | 8.61%796.52B | 14.04%223.25B | 5.24%192.82B | 7.27%194.31B | 7.43%186.14B | 7.05%733.4B | 3.88%195.77B |
Gross profit | 6.73%95.48B | 11.21%103.2B | 14.45%103.81B | 10.31%379.05B | 19.05%106.09B | 10.91%89.47B | 6.20%92.79B | 4.90%90.7B | -6.59%343.61B | -13.03%89.11B |
Operating expense | 6.72%87.73B | 8.79%88.68B | 7.29%87.3B | 4.82%337.08B | 10.70%91.99B | 4.03%82.21B | 1.98%81.52B | 2.33%81.37B | -7.99%321.57B | -15.03%83.1B |
Operating profit | 6.83%7.76B | 28.77%14.52B | 76.87%16.51B | 90.45%41.96B | 134.61%14.09B | 341.28%7.26B | 51.63%11.27B | 34.41%9.34B | 20.01%22.03B | 28.85%6.01B |
Net non-operating interest income (expenses) | -17.20%-109M | 13.33%-104M | 37.59%-83M | 25.71%-468M | 26.95%-122M | 41.14%-93M | 24.05%-120M | 9.52%-133M | 1.25%-630M | 17.33%-167M |
Non-operating interest income | -9.18%89M | 140.68%142M | 165.85%109M | 122.95%272M | 184.62%74M | 188.24%98M | 145.83%59M | 7.89%41M | -18.12%122M | -51.85%26M |
Non-operating interest expense | 3.66%198M | 37.43%246M | 10.34%192M | -1.60%740M | 1.55%196M | -0.52%191M | -1.65%179M | -5.95%174M | -4.45%752M | -24.61%193M |
Net investment income | -538.00%-1.1B | 11.53%1.48B | 331.47%617M | -10.08%2.03B | 1,595.24%314M | -36.39%250M | -8.67%1.33B | -67.28%143M | 23.07%2.26B | -102.86%-21M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 61,350.00%1.23B | 7M | 186M | -2M | ||||||
Income from associates and other participating interests | -9.31%302M | 138.03%338M | -2.44%80M | -7.86%539M | -263.64%-18M | 41.70%333M | -32.06%142M | -36.92%82M | 14.71%585M | -62.07%11M |
Special income (charges) | 1.33%-444M | -3.69%-506M | 119.25%46M | 110.14%295M | 194.06%1.47B | -34.33%-450M | 36.38%-488M | 1.65%-239M | -104.07%-2.91B | -80.51%-1.57B |
Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---2.7B | ---- | ---- | ---- | ---- | --0 | ---- |
Less:Other special charges | -0.90%441M | 41.77%353M | -143.16%-82M | -6.16%1.37B | -34.54%487M | 40.38%445M | -17.82%249M | 95.88%190M | 464.34%1.46B | 415.25%744M |
Less:Write off | -40.00%3M | -35.98%153M | -26.53%36M | -28.85%1.03B | -10.11%738M | -72.22%5M | -48.49%239M | -66.44%49M | -20.69%1.45B | -25.57%821M |
Other non-operating income (expenses) | 28.97%414M | -10.97%414M | 6.22%256M | -22.33%1.46B | -2.71%430M | -48.89%321M | -10.23%465M | -16.32%241M | 43.10%1.88B | 6.76%442M |
Income before tax | 5.67%8.05B | 28.16%16.15B | 86.81%17.61B | 97.35%45.82B | 222.58%16.17B | 216.40%7.62B | 50.24%12.6B | 27.25%9.43B | 16.35%23.22B | 4.44%5.01B |
Income tax | -2.54%2.57B | 29.55%5.2B | 71.35%5.87B | 62.58%14.19B | 117.73%4.11B | 126.07%2.64B | 43.73%4.01B | 18.99%3.43B | 16.76%8.73B | 45.98%1.89B |
Net income | 10.06%5.48B | 27.50%10.95B | 95.63%11.74B | 118.30%31.63B | 285.98%12.06B | 300.80%4.98B | 53.49%8.59B | 32.53%6B | 16.11%14.49B | -10.92%3.13B |
Net income continuous operations | 10.01%5.48B | 27.51%10.95B | 95.63%11.74B | 118.30%31.63B | 285.95%12.06B | 301.21%4.98B | 53.49%8.59B | 32.50%6B | 16.11%14.49B | -10.89%3.13B |
Noncontrolling interests | 45.56%246M | 2,200.00%322M | 53.67%796M | -31.07%1.46B | 8.25%761M | -47.02%169M | -97.15%14M | -14.80%518M | 0.90%2.12B | -25.21%703M |
Net income attributable to the company | 8.81%5.24B | 23.95%10.63B | 99.60%10.94B | 143.92%30.17B | 366.56%11.3B | 421.45%4.81B | 67.98%8.57B | 39.87%5.48B | 19.18%12.37B | -5.69%2.42B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 8.81%5.24B | 23.95%10.63B | 99.60%10.94B | 143.92%30.17B | 366.56%11.3B | 421.45%4.81B | 67.98%8.57B | 39.87%5.48B | 19.18%12.37B | -5.69%2.42B |
Gross dividend payment | ||||||||||
Basic earnings per share | 12.87%26.4 | 26.12%52.39 | 102.57%53.58 | 147.36%146.19 | 371.69%54.81 | 422.10%23.39 | 70.25%41.54 | 42.20%26.45 | 21.60%59.1 | -3.65%11.62 |
Diluted earnings per share | 12.68%26.3323 | 26.12%52.39 | 102.57%53.58 | 147.36%146.19 | 372.14%54.81 | 428.24%23.3692 | 70.25%41.54 | 42.20%26.45 | 21.60%59.1 | -3.74%11.6088 |
Dividend per share | 0 | 0 | 0 | 13.64%25 | 13.64%25 | 0 | 0 | 0 | 0.00%22 | 0.00%22 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |